CytochromP450Enzyme

CytochromP450Enzyme refers to a large superfamily of heme-containing monooxygenases that catalyze oxidation reactions essential for the metabolism of many compounds. These enzymes are primarily membrane-bound proteins located in the endoplasmic reticulum of liver and other tissues, with a subset residing in mitochondria. The active site contains a heme iron coordinated by a cysteine thiolate ligand. Electron transfer from NADPH via the P450 reductase and, in some cases, cytochrome b5 enables the activation of molecular oxygen and insertion of one oxygen atom into substrates while reducing the other to water.

CytochromP450 enzymes metabolize endogenous substrates such as steroids, fatty acids, and bile acids, as well as a broad array of xenobiotics, including many drugs. They exhibit broad yet selective substrate ranges and substantial isoform-specific activity. The most clinically important human isoforms include CYP3A4, CYP2D6, CYP2C9, CYP2C19, and CYP1A2, each with distinct tissue distribution and regulation. They can be induced or inhibited by various chemicals, altering drug clearance and response.

Genetic variation in CYP genes contributes to interindividual and interethnic differences in drug metabolism, giving rise to poor, intermediate, rapid, or ultra-rapid metabolizer phenotypes. Such polymorphisms influence drug efficacy and risk of adverse effects and underlie many drug–drug interactions. In addition to drug metabolism, P450 enzymes can activate or detoxify environmental procarcinogens and other toxicants, making them important in toxicology and pharmacology. Research and clinical testing often aim to predict metabolic phenotypes to optimize dosing.